Disclosures for "Vaporized Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial"
-
Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Schedule 1 Therapeutics. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Averitas. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ShiraTronics. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Syneos. Dr. Schuster has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura Fertin. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eli Lilly & Co. Dr. Schuster has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Averitas. Dr. Schuster has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for LITILI. Dr. Schuster has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sutton Pierce. The institution of Dr. Schuster has received research support from Migraine Research Foundation. The institution of Dr. Schuster has received research support from Novaremed. The institution of Dr. Schuster has received research support from UCSD Academic Senate.
-
Dr. WALLACE has nothing to disclose.
-
Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Collegium. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
-
Thomas Marcotte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seacoast Science. Thomas Marcotte has received research support from NIH. Thomas Marcotte has received research support from State of California. Thomas Marcotte has received research support from Wholistic Foundation. Thomas Marcotte has received publishing royalties from a publication relating to health care.
-
Mr. Lee has nothing to disclose.
-
Dr. Liu has nothing to disclose.
-
Mr. Sexton has nothing to disclose.